Sun Pharmaceutical Industries Share Price Today - Live Blog for August 06, 2025

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.15% decline, and it currently trades at ₹1,592.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd experienced a -0.30% downturn in its share price, and it's currently trading at ₹1,593.05. This situation is generating interest among value investors who are evaluating the stock's potential.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.16% in its share price, and it currently trades at ₹1,598.00 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

After a -0.16% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,598.00. The stock has a PE ratio of 37.7600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

There were no alterations in the share price of Sun Pharmaceutical Industries Ltd, and it is currently trading at ₹1,600.50. The stock has a PE ratio of 37.7600, an ROE of 15.1334%, and a debt to equity ratio of 0.0327.

With a -0.17% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,600.50. This development raises questions about the factors behind the decline. The stock's PE ratio is 37.7600, while the industry PE is 34.7036.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.27%, reaching a current market price of ₹1,606.05. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.52% drop, and it's now trading at ₹1,612.15 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

With a -0.00% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,620.35. The stock is currently trading at a PE of 37.7600, while the industry PE is 34.7036, prompting investors to assess its value proposition.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.08%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,619.75, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.00% uptick, and they are currently valued at ₹1,621.05, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.12% increase and currently trading at ₹1,621.00 per share. This upward trajectory is turning heads in the market.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.22%, reaching the current market value of ₹1,621.30 per share. This surge is a testament to the stock's recent performance.

After a significant 0.22% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,621.30 in the current market. This upward movement is attracting attention from both retail and institutional investors.

After a notable 0.22% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,621.30. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd share price surged by 0.02%. With its current market price standing at ₹1,616.95 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.02% increase in its share price and is currently trading at ₹1,616.95. This remarkable performance has caught the eye of investors.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.10%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,616.80 per share.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.07%, signalling a challenging period. Currently trading at ₹1,615.15, this stock has caught the eye of bargain hunters, who may be considering their entry points.

After a -0.24% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,615.50. The stock has a PE ratio of 37.7600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Following a noteworthy 0.14% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,618.60. When it comes to valuation, this stock has a PE ratio of 37.7600, with the industry PE ratio at 34.7036.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.08% decline, and it currently trades at ₹1,616.40 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.23%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,617.70 per share.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.21% decline and is currently trading at ₹1,614.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.43% recently. As of now, this stock is actively trading at a current market price of ₹1,617.45 per share, attracting attention from investors.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.04% increase and currently trading at ₹1,611.00 per share. Investors are taking notice of this upward momentum.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.83% drop, and it's now trading at ₹1,611.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.